{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:11:31Z","timestamp":1792980691811,"version":"4.5.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.cca.2013.12.001","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T02:00:28Z","timestamp":1386640828000},"page":"111-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["HDL-cholesterol in coronary artery disease risk: Function or structure?"],"prefix":"10.1016","volume":"429","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6977-1829","authenticated-orcid":false,"given":"\u00d3scar","family":"P\u00e9rez-M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor Gonz\u00e1lez","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Mart\u00ednez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.12.001_bb0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High-density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.cca.2013.12.001_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.12.001_bb0015","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","article-title":"Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"104","author":"Sharrett","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.12.001_bb0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.12.001_bb0025","article-title":"Cardioprotective functions of HDL","author":"Rye","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0030","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.cca.2013.12.001_bb0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cca.2010.10.021","article-title":"Lipid plasma concentrations of HDL subclasses determined by enzymatic staining on polyacrylamide electrophoresis gels in children with metabolic syndrome","volume":"412","author":"Garc\u00eda-S\u00e1nchez","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.mol.0000226116.35555.eb","article-title":"Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages","volume":"17","author":"Jessup","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0045","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/ATVBAHA.112.300133","article-title":"High-density lipoprotein function, dysfunction, and reverse cholesterol transport","volume":"32","author":"Fisher","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11883-011-0172-5","article-title":"Role of phospholipid transfer protein in high-density lipoprotein-mediated reverse cholesterol transport","volume":"13","author":"Yazdanyar","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cca.2013.12.001_bb0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01250","article-title":"Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis","volume":"421","author":"Martinez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cca.2013.12.001_bb0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cca.2013.12.001_bb0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0026-0495(97)90180-3","article-title":"Fish-eye disease: structural and in vivo metabolic abnormalities of high-density lipoproteins","volume":"46","author":"Elkhalil","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2013.12.001_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.mol.0000169350.45944.d4","article-title":"The role of the kidney in lipid metabolism","volume":"16","author":"Moestrup","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0075","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2174\/157016112803520972","article-title":"Therapeutic targets to raise HDL in patients at risk or with coronary artery disease","volume":"10","author":"L\u00fcscher","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.cca.2013.12.001_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.12.001_bb0085","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/89986","article-title":"High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase","volume":"7","author":"Yuhanna","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2013.12.001_bb0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1067\/mhj.2002.123145","article-title":"A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression","volume":"144","author":"Kuvin","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2013.12.001_bb0095","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1074\/jbc.M211394200","article-title":"High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases","volume":"278","author":"Mineo","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0100","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1194\/jlr.R037762","article-title":"High-density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease","volume":"54","author":"Riwanto","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0105","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1172\/JCI115532","article-title":"Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein","volume":"88","author":"Navab","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.12.001_bb0110","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.ATV.15.11.1987","article-title":"High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules","volume":"15","author":"Cockerill","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/bbrc.1997.7236","article-title":"Inhibition of VCAM-1 expression in endothelial cells by reconstituted high-density lipoproteins","volume":"238","author":"Calabresi","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2013.12.001_bb0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1357-2725(02)00173-5","article-title":"Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression","volume":"35","author":"Park","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/bbrc.1999.1278","article-title":"Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice","volume":"264","author":"Dimayuga","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2013.12.001_bb0130","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.RES.0000124302.20396.B7","article-title":"Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt\/endothelial nitric oxide synthase","volume":"94","author":"Viswambharan","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.RES.0000199272.59432.5b","article-title":"High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I","volume":"98","author":"Seetharam","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0140","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.CIR.0000013424.28206.8F","article-title":"High-density lipoprotein restores endothelial function in hypercholesterolemic men","volume":"105","author":"Spieker","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.12.001_bb0145","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2005.11.040","article-title":"Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano","volume":"47","author":"Nicholls","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2013.12.001_bb0150","doi-asserted-by":"crossref","first-page":"37457","DOI":"10.1074\/jbc.M605823200","article-title":"Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells","volume":"281","author":"Kimura","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1507\/endocrj.K08E-228","article-title":"Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I","volume":"56","author":"Okajima","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.cca.2013.12.001_bb0160","doi-asserted-by":"crossref","first-page":"C739","DOI":"10.1152\/ajpcell.00055.2011","article-title":"Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1","volume":"301","author":"Liu","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cca.2013.12.001_bb0165","first-page":"G393","article-title":"Prostaglandin endoperoxide synthase: why two isoforms?","volume":"270","author":"Williams","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cca.2013.12.001_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH07-11-0675","article-title":"Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin","volume":"100","author":"Gonzalez-Diez","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cca.2013.12.001_bb0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2004.01.037","article-title":"Simvastatin potentiates PGI2 release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL","volume":"174","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2013.12.001_bb0180","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.ATV.zhq0504.1403","article-title":"HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK\/CRE-dependent pathway: effects on COX-2\/PGI-synthase coupling","volume":"24","author":"Norata","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00041433-200210000-00005","article-title":"Cyclooxygenase-2 atherosclerosis","volume":"13","author":"Linton","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cca.2013.12.001_bb0195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI117342","article-title":"Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions","volume":"94","author":"Daugherty","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.12.001_bb0200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/emmm.201200224","article-title":"Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease","volume":"4","author":"Besler","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.cca.2013.12.001_bb0205","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MOL.0b013e32833bcdc1","article-title":"Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities","volume":"21","author":"Kontush","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0210","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.12.001_bb0215","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1074\/jbc.M107440200","article-title":"Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism","volume":"277","author":"Deakin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0220","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/01.ATV.0000091338.93223.E8","article-title":"Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress","volume":"23","author":"Kontush","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0225","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11745-013-3779-1","article-title":"Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability","volume":"48","author":"Kotosai","year":"2013","journal-title":"Lipids"},{"key":"10.1016\/j.cca.2013.12.001_bb0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MOL.0b013e32835ffcfd","article-title":"Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion","volume":"24","author":"Aviram","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0235","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(95)92709-3","article-title":"Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes","volume":"346","author":"Ruiz","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2013.12.001_bb0240","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1172\/JCI118373","article-title":"A variant of human paraoxonase\/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease","volume":"96","author":"Serrato","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.12.001_bb0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ymgme.2011.09.018","article-title":"Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies","volume":"105","author":"Zhao","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2013.12.001_bb0250","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.12.001_bb0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.diabres.2012.10.022","article-title":"Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes","volume":"99","author":"Murakami","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cca.2013.12.001_bb0260","first-page":"1020","article-title":"Associations between high-density lipoprotein mean particle size and serum paraoxonase-1 activity","volume":"17","author":"Razavi","year":"2012","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.cca.2013.12.001_bb0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2012.10.044","article-title":"Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: a practical zymogram method to assess HDL function","volume":"415","author":"Gugliucci","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0270","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1373\/clinchem.2006.074559","article-title":"Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay","volume":"53","author":"Browne","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0275","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.108.836346","article-title":"Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy","volume":"121","author":"Sorrentino","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.12.001_bb0280","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pharmthera.2012.12.001","article-title":"Inflammation alters HDL composition and function: implications for HDL-raising therapies","volume":"137","author":"Marsche","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cca.2013.12.001_bb0285","doi-asserted-by":"crossref","first-page":"32172","DOI":"10.1074\/jbc.M200503200","article-title":"Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport","volume":"277","author":"Marsche","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0290","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2013.12.001_bb0295","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.12.001_bb0300","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.ATV.0000148703.43429.25","article-title":"2-Chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis","volume":"24","author":"Marsche","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cvr\/cvn051","article-title":"Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro","volume":"79","author":"Marsche","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0310","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/ATVBAHA.107.141747","article-title":"HDL oxidation compromises its influence on paraoxonase-1 secretion and its capacity to modulate enzyme activity","volume":"27","author":"Deakin","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0315","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/ars.2011.4403","article-title":"Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein","volume":"17","author":"Holzer","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.cca.2013.12.001_bb0320","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","article-title":"Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodelling","volume":"127","author":"Riwanto","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.12.001_bb0325","first-page":"522","article-title":"Regulation of ABCA1 functions by signaling pathways","volume":"2012","author":"Liu","year":"1821","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0330","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.atherosclerosis.2010.05.035","article-title":"Anti-inflammatory effects of apolipoprotein A-I in the rabbit","volume":"212","author":"Patel","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2013.12.001_bb0335","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4331\/wjbc.v1.i11.327","article-title":"Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein","volume":"1","author":"Sato","year":"2010","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0340","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cellsig.2005.07.011","article-title":"Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells","volume":"18","author":"Kimura","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.cca.2013.12.001_bb0345","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MOL.0b013e328361f822","article-title":"HDL quality or cholesterol cargo: what really matters\u2014spotlight on sphingosine-1-phosphate-rich HDL","volume":"24","author":"Egom","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0350","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/ATVBAHA.106.136325","article-title":"High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans","volume":"27","author":"Birjmohun","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0355","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.110.961193","article-title":"High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide","volume":"122","author":"Suzuki","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.12.001_bb0360","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cvr\/cvs089","article-title":"High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A","volume":"94","author":"T\u00f6lle","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0365","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.12.001_bb0370","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0375","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2013.12.001_bb0380","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of HDL: association of acute phase proteins and complement factors with pro-inflammatory HDL in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2013.12.001_bb0385","first-page":"405","article-title":"The HDL proteome in acute coronary syndromes shifts to an inflammatory profile","volume":"2012","author":"Alwaili","year":"1821","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0390","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0022-2275(20)33462-3","article-title":"Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3","volume":"41","author":"Navab","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0395","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.2337\/db11-0378","article-title":"Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes","volume":"60","author":"Morgantini","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2013.12.001_bb0400","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.CIR.0000103624.14436.4B","article-title":"Inflammatory\/anti-inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favourably affected by simvastatin treatment","volume":"108","author":"Ansell","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.12.001_bb0405","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-511X-11-87","article-title":"Effects of lipid\u2013probe interactions in biochemical fluorometric methods that assess HDL redox activity","volume":"11","author":"Kelesidis","year":"2012","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.cca.2013.12.001_bb0410","author":"CDC"},{"key":"10.1016\/j.cca.2013.12.001_bb0415","author":"CDC"},{"key":"10.1016\/j.cca.2013.12.001_bb0420","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0021-9150(99)00279-8","article-title":"Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris","volume":"148","author":"P\u00e9rez-M\u00e9ndez","year":"2000","journal-title":"Atherosclerosis"},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2013.12.001_bb0425","first-page":"77","article-title":"Kinetic and metabolic studies of apo A-I and apo A-II in an hypoalphalipoproteinemic patient","volume":"2","author":"P\u00e9rez-M\u00e9ndez","year":"1995","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cca.2013.12.001_bb0430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.107.161711","article-title":"Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1","volume":"102","author":"Out","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0435","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.amjcard.2013.05.049","article-title":"Predictive value of vipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120mg\/dl","volume":"112","author":"Tanaka","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2013.12.001_bb0440","doi-asserted-by":"crossref","first-page":"176","DOI":"10.5551\/jat.9183","article-title":"Usefulness of LDL-C-related parameters to predict cardiovascular risk and effect of pravastatin in mild-to-moderate hypercholesterolemia","volume":"19","author":"Mizuno","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.cca.2013.12.001_bb0445","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jns.2013.01.019","article-title":"Impact of low-density lipoprotein to high-density lipoprotein ratio on aortic arch atherosclerosis in unexplained stroke","volume":"326","author":"Okuzumi","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.cca.2013.12.001_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07315724.2008.10719668","article-title":"The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk","volume":"27","author":"Fernandez","year":"2008","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.cca.2013.12.001_bb0455","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.12.001_bb0460","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/en.2008-1512","article-title":"Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition","volume":"150","author":"Hu","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2013.12.001_bb0465","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/eurheartj\/ehr348","article-title":"Torcetrapib impairs endothelial function in hypertension","volume":"33","author":"Simic","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2013.12.001_bb0470","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MOL.0b013e3283475e00","article-title":"Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism","volume":"22","author":"Niesor","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0475","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1517\/13543784.2012.699040","article-title":"Dalcetrapib, a cholesteryl ester transfer protein modulator","volume":"21","author":"Hooper","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.cca.2013.12.001_bb0480","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1194\/jlr.M008706","article-title":"Modulating cholesteryl ester transfer protein activity maintains efficient pre-\u03b2-HDL formation and increases reverse cholesterol transport","volume":"51","author":"Niesor","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0485","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.12.001_bb0490","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40262-013-0071-8","article-title":"Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective","volume":"52","author":"Mohammadpour","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cca.2013.12.001_bb0495","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jama.298.7.786","article-title":"High-density lipoprotein as a therapeutic target: a systematic review","volume":"298","author":"Singh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2013.12.001_bb0500","doi-asserted-by":"crossref","first-page":"25713","DOI":"10.1074\/jbc.273.40.25713","article-title":"The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates","volume":"273","author":"Vu-Dac","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0505","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11883-001-0015-x","article-title":"The role of fibric acids in atherosclerosis","volume":"3","author":"Fruchart","year":"2001","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cca.2013.12.001_bb0510","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2840-11-125","article-title":"Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction","volume":"11","author":"Tenenbaum","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cca.2013.12.001_bb0515","series-title":"HDL and LDL cholesterol: physiology and clinical significance","first-page":"145","article-title":"HDL physicochemical characteristics as determinants of their plasma concentrations: what we have learned from thiazolidinediones","author":"P\u00e9rez-M\u00e9ndez","year":"2009"},{"key":"10.1016\/j.cca.2013.12.001_bb0520","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cca.2006.02.041","article-title":"A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry","volume":"369","author":"McNamara","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0525","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/oby.2000.9","article-title":"Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: a comparison of African and white Americans","volume":"8","author":"MacLean","year":"2000","journal-title":"Obes Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0530","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1161\/CIRCULATIONAHA.104.512079","article-title":"Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study","volume":"111","author":"Festa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.12.001_bb0535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/hq1001.096624","article-title":"Niacin, but not gemfibrozil, selectively increases LPAI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol","volume":"21","author":"Sakai","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0540","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1567-5688(05)80214-4","article-title":"Ciprofibrate enhances cholesterol efflux and paraoxonase-1 association with HDL in hypertriglyceridemic patients","volume":"6","author":"P\u00e9rez-M\u00e9ndez","year":"2005","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.cca.2013.12.001_bb0545","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2004.12.047","article-title":"Pioglitazone increases the fractional catabolic and production rates of high-density lipoproteins apo AI in the New Zealand White Rabbit","volume":"181","author":"Carre\u00f3n-Torres","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2013.12.001_bb0550","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cca.2008.11.003","article-title":"Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates","volume":"401","author":"Carre\u00f3n-Torres","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0555","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages","volume":"30","author":"de la Llera-Moya","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0560","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1373\/clinchem.2009.139931","article-title":"High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol","volume":"56","author":"Sethi","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0565","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/clinchem\/37.3.377","article-title":"Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy","volume":"37","author":"Otvos","year":"1991","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0570","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0022-2275(20)42753-1","article-title":"Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis","volume":"31","author":"Williams","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0575","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0022-2275(20)41167-8","article-title":"Analysis of high density lipoproteins by a modified gradient gel electrophoresis method","volume":"35","author":"Li","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0580","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2006.07.003","article-title":"Abnormal HDL subclasses distribution in overweight children with insulin resistance or type 2 diabetes mellitus","volume":"376","author":"P\u00e9rez-M\u00e9ndez","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0585","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/met.2011.0071","article-title":"The srb1+1050T allele is associated with metabolic syndrome in children but not with cholesteryl ester plasma concentrations of high-density lipoprotein subclasses","volume":"10","author":"Ju\u00e1rez-Meavepe\u00f1a","year":"2012","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.cca.2013.12.001_bb0590","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1194\/jlr.D004358","article-title":"Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclasses","volume":"51","author":"Toledo-Ibelles","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0595","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1161\/01.ATV.20.12.2670","article-title":"Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease","volume":"20","author":"Asztalos","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0600","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-60327-369-5_17","article-title":"Native\u2013native 2D gel electrophoresis for HDL subpopulation analysis","volume":"1027","author":"Freeman","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0605","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum","volume":"22","author":"Chapman","year":"1981","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0610","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/01.ATV.17.4.786","article-title":"Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis","volume":"17","author":"Goulinet","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0615","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-2275(20)40123-3","article-title":"Quantification of cholesterol in all lipoprotein classes by the VAP-II method","volume":"35","author":"Kulkarni","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0620","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0022-2275(20)39710-8","article-title":"Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology","volume":"36","author":"Kulkarni","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0625","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0022-2275(20)34949-X","article-title":"Quantification of HDL2 and HDL3 cholesterol by the Vertical Auto Profile-II (VAP-II) methodology","volume":"38","author":"Kulkarni","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0630","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1373\/clinchem.2005.059949","article-title":"Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics","volume":"52","author":"Ensign","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0635","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1194\/jlr.M300395-JLR200","article-title":"Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis","volume":"45","author":"Colhoun","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0640","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/clinchem\/38.9.1632","article-title":"Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement","volume":"38","author":"Otvos","year":"1992","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0645","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1053\/meta.2001.21027","article-title":"Distribution and correlates of high-density lipoprotein subclasses among children and adolescents","volume":"50","author":"Freedman","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2013.12.001_bb0650","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/bi00401a005","article-title":"Early incorporation of cell-derived cholesterol into pre-\u00df-migrating high density lipoprotein pathway","volume":"27","author":"Castro","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2013.12.001_bb0655","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9149(02)02427-X","article-title":"Relations of lipoprotein subclass levels and LDL size to progression of coronary artery disease in the PLAC-I trial","volume":"90","author":"Rosenson","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2013.12.001_bb0660","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.105.565135","article-title":"LDL and HDL particle subclasses predict coronary events and are changed favorably by gemfibrozil therapy in the Veterans Affairs HDL Intervention Trial (VA-HIT)","volume":"113","author":"Otvos","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2013.12.001_bb0665","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2006.05.007","article-title":"LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"192","author":"Mora","year":"2007","journal-title":"Atherosclerosis"},{"issue":"Suppl. A","key":"10.1016\/j.cca.2013.12.001_bb0670","first-page":"A298","article-title":"Low cholesterol and phosphatidylcholine plasma concentrations of high-density lipoproteins subclasses in subjects with coronary calcium score above the 75th percentile for age and gender","volume":"61","author":"P\u00e9rez-Mendez","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2013.12.001_bb0675","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"60","author":"Mackey","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2013.12.001_bb0680","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2013.12.001_bb0685","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db09-1114","article-title":"Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women","volume":"59","author":"Mora","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2013.12.001_bb0690","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jacl.2010.11.007","article-title":"Differences in lipoprotein particle subclass distribution for Japanese Americans in Hawaii and Japanese in Japan: the INTERLIPID study","volume":"5","author":"Curb","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0695","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3899\/jrheum.090639","article-title":"Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis","volume":"37","author":"Chung","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2013.12.001_bb0700","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/03009740802541470","article-title":"Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease","volume":"38","author":"Hua","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cca.2013.12.001_bb0705","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1253\/circj.CJ-08-0582","article-title":"Altered flow mediated vasodilatation, low paraoxonase-1 activities, and abnormal high-density lipoprotein subclasses distribution in Takayasu's arteritis","volume":"73","author":"Espinola-Zavaleta","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.cca.2013.12.001_bb0710","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1017\/S0007114510001595","article-title":"High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: the Rancho Bernardo Study","volume":"104","author":"Muth","year":"2010","journal-title":"Br J Nutr"},{"key":"10.1016\/j.cca.2013.12.001_bb0715","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5551\/jat.E563","article-title":"Effects of atorvastatin on nuclear magnetic resonance-defined lipoprotein subclasses and inflammatory markers in patients with hypercholesterolemia","volume":"16","author":"Ikewaki","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.cca.2013.12.001_bb0720","first-page":"603","article-title":"NMR-determined lipoprotein subclass profile is associated with dietary composition and body size","volume":"21","author":"Hodge","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.cca.2013.12.001_bb0725","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2265.2011.04195.x","article-title":"Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size","volume":"76","author":"Makimura","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.cca.2013.12.001_bb0730","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/meta.2002.31323","article-title":"Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat","volume":"51","author":"Huesca-G\u00f3mez","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2013.12.001_bb0735","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cca.2006.10.019","article-title":"Palmitic acid reduces the fractional catabolic rates of HDL apo A-I in vivo: contribution of the surface negative charge","volume":"378","author":"P\u00e9rez-M\u00e9ndez","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0740","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.2337\/diabetes.47.12.1928","article-title":"In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance","volume":"47","author":"Pietzsch","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2013.12.001_bb0745","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s001250050718","article-title":"High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study","volume":"40","author":"Fr\u00e9nais","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2013.12.001_bb0750","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/oby.2005.118","article-title":"High-density lipoprotein apolipoprotein A-I kinetics in obesity","volume":"13","author":"Ooi","year":"2005","journal-title":"Obes Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0755","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1194\/jlr.M300422-JLR200","article-title":"Prebeta high density lipoprotein has two metabolic fates in human apolipoprotein A-I transgenic mice","volume":"45","author":"Lee","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0760","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1016\/S0021-9258(18)32346-9","article-title":"Tissue sites of degradation of apoprotein A-I in the rat","volume":"258","author":"Glass","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0765","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clinbiochem.2007.10.007","article-title":"The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients","volume":"41","author":"Cho","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2013.12.001_bb0770","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cca.2013.12.001_bb0775","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cca.2012.09.028","article-title":"Shift of high-density lipoprotein size distribution toward large particles in patients with proteinuria","volume":"414","author":"Soto-Miranda","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0780","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.metabol.2012.09.010","article-title":"Normal HDL-apo AI turnover and cholesterol enrichment of HDL subclasses in New Zealand rabbits with partial nephrectomy","volume":"62","author":"Toledo-Ibelles","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2013.12.001_bb0785","doi-asserted-by":"crossref","first-page":"11687","DOI":"10.1073\/pnas.1209305109","article-title":"Apolipoprotein A-I helical structure and stability in discoidal high-density lipoprotein (HDL) particles by hydrogen exchange and mass spectrometry","volume":"109","author":"Sevugan Chetty","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2013.12.001_bb0790","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1021\/bi700496w","article-title":"Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning","volume":"46","author":"Pownall","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2013.12.001_bb0795","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1375\/twin.10.5.703","article-title":"Heritability of longitudinal measures of body mass index and lipid and lipoprotein levels in aging twins","volume":"10","author":"Goode","year":"2007","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/j.cca.2013.12.001_bb0800","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MOL.0b013e328306a043","article-title":"The value of HDL genetics","volume":"19","author":"Holleboom","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0805","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11883-013-0326-8","article-title":"Genetics of HDL-C: a causal link to atherosclerosis?","volume":"15","author":"van Capelleveen","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cca.2013.12.001_bb0810","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.cca.2011.05.035","article-title":"Cardiovascular diseases and genome-wide association studies","volume":"412","author":"Ndiaye","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.12.001_bb0815","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1194\/jlr.R004739","article-title":"Genetic causes of high and low serum HDL-cholesterol","volume":"51","author":"Weissglas-Volkov","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0820","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.cca.2013.12.001_bb0825","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Deloukas","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.cca.2013.12.001_bb0830","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2013.12.001_bb0835","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MOL.0b013e3283468061","article-title":"Metabolic and functional relevance of HDL subspecies","volume":"22","author":"Asztalos","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2013.12.001_bb0840","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1074\/mcp.M113.028134","article-title":"Multi-dimensional co-separation analysis reveals protein:protein interactions defining plasma lipoprotein subspecies","volume":"12","author":"Gordon","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cca.2013.12.001_bb0845","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/ATVBAHA.108.179317","article-title":"Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins","volume":"30","author":"Davidsson","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0850","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1161\/ATVBAHA.113.301468","article-title":"Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities","volume":"33","author":"Camont","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2013.12.001_bb0855","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1073\/pnas.89.21.10316","article-title":"High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors","volume":"89","author":"Bowry","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2013.12.001_bb0860","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1074\/jbc.273.11.6080","article-title":"Oxidation of high-density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol","volume":"273","author":"Garner","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.12.001_bb0870","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0875","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-2275(20)36996-0","article-title":"Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias","volume":"17","author":"Dawson","year":"1976","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.12.001_bb0880","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1432-1033.1989.tb14773.x","article-title":"Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins","volume":"181","author":"Senn","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.cca.2013.12.001_bb0885","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2362.1999.00438.x","article-title":"Distribution of diacylglycerols among plasma lipoproteins in control subjects and in patients with non-insulin-dependent diabetes","volume":"29","author":"Lalanne","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cca.2013.12.001_bb0890","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unravelling the complexities of the HDL lipidome","volume":"54","author":"Kontush","year":"2013","journal-title":"J Lipid Res"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113004853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113004853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T11:05:25Z","timestamp":1647687925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113004853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":177,"alternative-id":["S0009898113004853"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.12.001","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDL-cholesterol in coronary artery disease risk: Function or structure?","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}